Neuraxpharm and partner Minoryx Therapeutics, meanwhile, were unable to convince the CHMP that they should get conditional approval for PPAR gamma agonist Nezglyal (leriglitazone) as a treatment ...
The CHMP has backed the drug as a treatment for FA in patients aged 16 years and older, a few months after Skyclarys (omaveloxolone) was approved by the FDA for the same indication, and shortly ...
With many engineers seeking training programs that offer these credits, IEEE can help you provide these benefits to your professionals through the IEEE Credentialing Program. All applications for the ...
Start verifying identities using Face Check with Microsoft Entra Verified ID—included in the Microsoft Entra Suite.
21 March 2025 China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results